tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Arrowhead Pharmaceuticals’ ARO-C3: Promising Early Data with Hold Rating Amid Competitive Landscape
RatingsArrowhead Pharmaceuticals’ ARO-C3: Promising Early Data with Hold Rating Amid Competitive Landscape
1d ago
ARWR
Arrowhead data supports blockbuster potential of ARO-C3, says H.C. Wainwright
PremiumThe Fly
Arrowhead data supports blockbuster potential of ARO-C3, says H.C. Wainwright
2d ago
ARWR
Buy Rating for Arrowhead Pharmaceuticals Driven by Promising ARO-C3 Trial Results and Strategic Pipeline Advancements
PremiumRatings
Buy Rating for Arrowhead Pharmaceuticals Driven by Promising ARO-C3 Trial Results and Strategic Pipeline Advancements
2d ago
ARWR
Arrowhead announces topline results from ARO-C3 trial
PremiumThe Fly
Arrowhead announces topline results from ARO-C3 trial
2d ago
ARWR
Arrowhead presents data on candidates to treat obesity, metabolic diseases
PremiumThe Fly
Arrowhead presents data on candidates to treat obesity, metabolic diseases
6d ago
ARWR
Arrowhead presents preclinical results on ARO-ALK7
PremiumThe FlyArrowhead presents preclinical results on ARO-ALK7
15d ago
ARWR
Arrowhead price target lowered to $38 from $51 at B. Riley
Premium
The Fly
Arrowhead price target lowered to $38 from $51 at B. Riley
26d ago
ARWR
IONS
Arrowhead Pharmaceuticals: Promising Pipeline Amidst Cautious Financial Outlook Warrants Hold Rating
Premium
Ratings
Arrowhead Pharmaceuticals: Promising Pipeline Amidst Cautious Financial Outlook Warrants Hold Rating
28d ago
ARWR
Arrowhead Pharmaceuticals: Promising Drug Approval and Expanding Pipeline Justify Buy Rating
PremiumRatings
Arrowhead Pharmaceuticals: Promising Drug Approval and Expanding Pipeline Justify Buy Rating
28d ago
ARWR
Arrowhead Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Arrowhead Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
29d ago
ARWR
Arrowhead Pharmaceuticals: Promising Pipeline and Strategic Developments Drive Buy Rating
PremiumRatings
Arrowhead Pharmaceuticals: Promising Pipeline and Strategic Developments Drive Buy Rating
29d ago
ARWR
Arrowhead Pharmaceuticals Reports Q1 2025 Financial Results
PremiumCompany Announcements
Arrowhead Pharmaceuticals Reports Q1 2025 Financial Results
30d ago
ARWR
Arrowhead Pharmaceuticals: Strategic Licensing Deal and Upcoming Drug Launch Drive Buy Rating
PremiumRatingsArrowhead Pharmaceuticals: Strategic Licensing Deal and Upcoming Drug Launch Drive Buy Rating
30d ago
ARWR
Arrowhead reports Q1 EPS ($1.39), consensus (72c)
Premium
The Fly
Arrowhead reports Q1 EPS ($1.39), consensus (72c)
30d ago
ARWR
Arrowhead to receives $500M upfront in licensing pact with Sarepta
Premium
The Fly
Arrowhead to receives $500M upfront in licensing pact with Sarepta
1M ago
ARWR
SRPT
Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 Earnings Cheat Sheet
1M ago
ARWR
Arrowhead Pharmaceuticals Appoints Douglas Ingram as Director
PremiumCompany Announcements
Arrowhead Pharmaceuticals Appoints Douglas Ingram as Director
1M ago
8K
ARWR
Genelux names Matthew Pulisic as CFO, effective January 30
PremiumThe Fly
Genelux names Matthew Pulisic as CFO, effective January 30
1M ago
ARWR
GNLX
Closing Bell Movers: Electronic Arts down over 10% on guidance cut
PremiumThe Fly
Closing Bell Movers: Electronic Arts down over 10% on guidance cut
2M ago
AA
EA
Arrowhead up 4% at $20.51 after entry into S&P SmallCap 600 index
PremiumThe FlyArrowhead up 4% at $20.51 after entry into S&P SmallCap 600 index
2M ago
ARWR
Arrowhead to replace Barnes Group in S&P 600 at open on 1/27
Premium
The Fly
Arrowhead to replace Barnes Group in S&P 600 at open on 1/27
2M ago
B
APO
Guidewire to replace Arrowhead in S&P 400 index at open on 1/27
Premium
The Fly
Guidewire to replace Arrowhead in S&P 400 index at open on 1/27
2M ago
ARWR
GWRE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >